Source comparison
Best CJC-1295 Dosage Sleep 2026: Protocol Comparison
Acute Sleep Depth 200–300mcg 75–90 min pre-sleep No-DAC +20–28% Stage 3 duration Single-night or short-term studies targeting depth architecture Sustained Baseline Elevation 1–2mg Once weekly, any time DAC +8–12% Stage 3 (indirect) Multi-week anabolic studies
This comparison does not assign a generated winner or score.
- Acute Sleep Depth
- 200–300mcg
- 75–90 min pre-sleep
- No-DAC
- +20–28% Stage 3 duration
- Single-night or short-term studies targeting depth architecture
- Sustained Baseline Elevation
- 1–2mg
- Once weekly, any time
- DAC
- +8–12% Stage 3 (indirect)
- Multi-week anabolic studies with secondary sleep endpoints
- Pulse Amplification
- 400–500mcg
- 60 min pre-sleep
- +18–24% Stage 3, +15% REM latency reduction
- Protocols studying GH-adenosine pathway specifically
- Low-Dose Threshold
- 100–150mcg
- 90 min pre-sleep
- +6–10% Stage 3 (minimal)
- Dose-finding studies or sensitivity testing
- High-Dose Saturation
- 600–1000mcg
- 75 min pre-sleep
- +22–26% Stage 3 (plateaus vs 400mcg)
- Testing receptor ceiling effects. Not recommended for efficiency